Stay updated on Cabozantinib for Young Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Young Solid Tumors Clinical Trial page.

Latest updates to the Cabozantinib for Young Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedUpdated page version to v3.2.0 and added a government operating-status notice; removed mention of Medullary thyroid carcinoma under Genetic and Rare Diseases Information Center and old version v3.1.0.SummaryDifference3%

- Check26 days agoChange DetectedUpdate term from 'Medullary thyroid gland carcinoma' to 'Medullary thyroid carcinoma' and bump version from v3.0.2 to v3.1.0.SummaryDifference0.1%

- Check40 days agoChange DetectedUpdated the page revision from v3.0.1 to v3.0.2, indicating a version upgrade. The 'Back to Top' link was removed, with no other substantive changes to pricing, stock, times, or names.SummaryDifference0.1%

- Check47 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.1%

- Check55 days agoChange DetectedThe web page has added significant information regarding facility names and locations, as well as related medical topics such as melanoma and thyroid cancer, while removing some redundant location details and specific drug information.SummaryDifference5%

- Check69 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib for Young Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Young Solid Tumors Clinical Trial page.